Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

18
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
18

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Interplay of Parental Leave, Career Achievement, and Burnout in Academic Neurologists: A Multicenter Study.

Journal of women's health (2002)·2026
Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

bioRxiv : the preprint server for biology·2026
Same author

Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility.

Neurology. Clinical practice·2026
Same author

Clinical Reasoning: A 28-Year-Old Man With Seizures and Thalamic Lesions.

Neurology·2026
Same author

Diffusion weighted imaging abnormalities and cerebral ischemia in a cohort of patients on lecanemab.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Aug 19, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.2K

Neuromyelitis optica: Clinical course and potential prognostic indicators.

Nidhila Masha1, Dorlan J Kimbrough2, Christopher P Eckstein2

  • 1Duke University School of Medicine, 8 Searle Center Dr, Durham, NC 27710, USA.

Multiple Sclerosis and Related Disorders
|December 4, 2022
PubMed
Summary

Neuromyelitis optica spectrum disorder (NMOSD) patients often show stable or improved disability, challenging previous views. Aquaporin-4 (AQP4) status and plasmapheresis did not significantly impact NMOSD prognosis in this study.

Keywords:
Aquaporin-4-IgGDevic's diseaseNeuromyelitis opticaPlasmapheresis

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.6K
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

23.5K

Related Experiment Videos

Last Updated: Aug 19, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.2K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.6K
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

23.5K

Area of Science:

  • Neurology
  • Immunology
  • Autoimmune Diseases

Background:

  • Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disorder.
  • It is characterized by antibodies targeting aquaporin-4 (AQP4).
  • NMOSD has been traditionally viewed as a progressive condition with accumulating disability.

Purpose of the Study:

  • To evaluate the longitudinal disease course in NMOSD patients.
  • To investigate the influence of AQP4 seropositivity, AQP4 serum titer levels, and plasmapheresis on NMOSD prognosis.

Main Methods:

  • Retrospective chart review of 53 NMOSD patients.
  • Collected data on disease course, imaging, demographics, and serum AQP4 titers.
  • Calculated disability progression using EDSS scores and analyzed correlations with prognostic factors.

Main Results:

  • Contrary to expectations, most patients showed no disability change (31.9%) or improvement (27.1%).
  • No significant association was found between prognosis and initial AQP4 seropositivity (p=0.830).
  • Initial AQP4 serum titer levels (p=0.338) and plasmapheresis (p=0.1149) also showed no significant correlation with prognosis.

Conclusions:

  • This study suggests a more favorable NMOSD disease course than previously reported, potentially due to modern treatments.
  • AQP4 seropositivity or titer levels may not reliably predict NMOSD prognosis.
  • Further research is needed to clarify the role of plasmapheresis in NMOSD treatment.